Data Cart

Your data extract

0 variables
0 samples
View Cart
GENTOVCAN
Had genetic test for ovarian cancer risk
Return to Genetic Testing variables list

Codes and Frequencies



Can't find the category you are looking for? Try the Detailed codes

Description

For female sample adults who ever had a genetic test to determine the risk of developing cancer in the future (GENTCANEV), GENTOVCAN indicates whether the respondent's most recent genetic test for cancer was for ovarian cancer.

 

Other choices asked about include:

GENTBCAN- Respondent's most recent genetic test was for breast cancer risk
GENTCOLCAN- Respondent's most recent genetic test was for colon/rectal cancer risk
GENTOTHCAN- Respondent's most recent genetic test was for other cancer risk

GENTOVCAN was included in a section of the Cancer Control Module dedicated to questions on genetic testing introduced in 2000. Interviewers began this part of the survey by reading the following statement:

The following questions refer to "genetic testing for cancer risk." That is, testing your blood to see if you carry genes which may predict a greater chance of developing cancer at some point in your life. This does NOT include tests to determine if you have cancer now.

The 2000 and 2005 Field Representative's Manual defines genetic testing as:

A blood test that assesses if the person has genes that predict a greater chance of developing cancer at some point in the lifespan. It does not include any of the tests that help determine if the person had cancer in the past, or has it now.

The 2010 Field Representative's Manual states that, "Genetic testing for cancer risk means testing the blood to determine if an individual carries genes which may predict a greater chance of developing cancer at some point in their lifetime."

Comparability

Changes in the universe may limit the comparability of 2015 to earlier years. In 2015, GENTOVCAN was asked of female sample adults who had undergone genetic testing to assess their risk of cancer. In 2005 and 2010, GENTOVCAN was asked of female sample adults who indicated they had heard of genetic testing to assess cancer risk and who had undergone genetic testing to assess their risk of cancer. In 2000, GENTOVCAN was asked of all sample adults who had heard of genetic testing to assess cancer risk and who had undergone genetic testing to assess their risk of cancer. Analysts will need to restrict the 2000 sample to female sample adults to compare to later years.

Universe

  • 2000; 2005; 2010: Female sample adults age 18+ who have had ever heard of genetic testing for cancer risk and underwent genetic testing for cancer risk.
  • 2015: Female sample adults age 18+ who have had genetic testing for cancer risk.

Availability

  • 2000, 2005, 2010, 2015

Weights